Otivio AS

Otivio AS is a Norwegian medical device company founded in 2010 and based in Oslo, with subsidiaries in Denmark and Germany. The company focuses on developing innovative, non-invasive medical devices that enhance patient self-care and treatment at home, particularly in the area of vascular health. Its flagship product, FlowOx™, is a CE-certified Class IIa medical device designed for treating peripheral arterial disease (PAD) and related conditions. FlowOx™ utilizes pulsating intermittent negative pressure (INP) therapy to improve blood circulation in the lower legs and feet, making it comfortable and suitable for home use. Clinical studies have shown that FlowOx™ can significantly increase blood flow, reduce pain, and promote wound healing. The device also has potential benefits for other conditions, such as Multiple Sclerosis, based on early patient data. Otivio collaborates with partners like Innokas Medical to enhance its product offerings, including the second-generation FlowOx 2.0, which features connectivity options. The company aims to empower patients and healthcare providers with effective home treatment solutions, ultimately improving quality of life and reducing healthcare costs associated with chronic conditions.

• Employees 8
• Founded 2010
• Total Funding $3286162